tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Neogen Corporation Reports Q4 2025 Financial Results

Neogen Corporation Reports Q4 2025 Financial Results

Neogen ( (NEOG) ) has released its Q4 earnings. Here is a breakdown of the information Neogen presented to its investors.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Neogen Corporation is a global leader in food safety, livestock, and pet health and wellness, providing comprehensive solutions through science and technology to ensure global food security. The company recently reported its fourth-quarter 2025 earnings, highlighting a revenue of $225.5 million and a significant net loss of $612.2 million, primarily due to a non-cash goodwill impairment related to a past acquisition. Despite the challenges, Neogen’s core mission remains focused on enhancing food safety and security worldwide.

In the fourth quarter, Neogen faced softer end-market conditions, resulting in a 4.8% decrease in revenue compared to the previous year. The company’s Food Safety segment saw a modest decline in revenue, while the Animal Safety segment experienced a more pronounced drop. The net loss was largely attributed to a goodwill impairment charge, though the company reported an adjusted net income of $11.3 million. The adjusted EBITDA for the quarter was $40.6 million, reflecting a decline from the previous year.

The company’s gross margin decreased to 41.2% due to transaction and integration-related costs, with the adjusted EBITDA margin also seeing a decline. Neogen’s strategic focus includes addressing the challenges in its sample collection product line and continuing the integration of its Petrifilm production. The company remains optimistic about its long-term growth drivers, supported by a favorable regulatory environment in the US.

Looking ahead, Neogen anticipates revenue for fiscal year 2026 to range between $820 million and $840 million, with adjusted EBITDA expected to be between $165 million and $175 million. The company plans to reduce capital expenditures significantly and aims to improve its financial position by repaying debt with proceeds from a recent divestiture. Neogen’s management remains committed to executing its strategic initiatives and is optimistic about the company’s future prospects.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1